a public good project by the
Synthesis
Company
of California

© 2026

Constance M. Cultraro | doi.page

0 works0 citations0 h-index

Constance M. Cultraro

National Institutes of Health(US)National Cancer Institute(US)Center for Cancer Research(US)

Publications by Year

Research Areas

Lung Cancer Treatments and Mutations, Synthesis and biological activity, Cytokine Signaling Pathways and Interactions, Quinazolinone synthesis and applications, Cancer Genomics and Diagnostics

Most-Cited Works

→ Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer(2020)174 cited
→ Genetic Variations at Loci Involved in the Immune Response Are Risk Factors for Hepatocellular Carcinoma(2010)154 cited
→ APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors(2019)107 cited
→ Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor–Driven Lung Adenocarcinoma(2015)75 cited
→ Function of the c-Myc Antagonist Mad1 during a Molecular Switch from Proliferation to Differentiation(1997)66 cited
→ Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance(2021)63 cited

→ Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response(2017)55 cited

→ Alternative splicing of human synexin mRNA in brain, cardiac, and skeletal muscle alters the unique N-terminal domain.(1991)55 cited

→ EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse models(2016)50 cited

→ A spatial map of hepatic mitochondria uncovers functional heterogeneity shaped by nutrient-sensing signaling(2024)49 cited